Clinical Trials Logo

Clinical Trial Summary

A qualitative study conducted in 2018 Exploring socio-cultural factors impacting adherence to type 2 diabetes therapy in rural Sargodha featured respondents who were primarily doctors, patients, and. Diet, exercise, and smoking were all variables. The void we investigators will fill will be comprised of several professionals assessing sleep and sedentary lifestyle. A book on anthropology published in 2021 shows the gap are still the same about sedentary life style. The investigators aim to determine lifestyle practices in relation to sedentary behaviour in different occupations & comparing which profession is prone to chronic diseases in accordance to lifestyle practices


Clinical Trial Description

Considering all the numerous variables that can have an effect on someone's health, it seems obvious that prior research into all the potential determinants of a health intervention's success is necessary. Care for a sickness requires knowledge of both the disease itself and the patient's social and cultural context, thus it's important to learn about both. Since diabetes is chronic, it must be managed permanently. IDF's most recent projections for 2019 show that the prevalence of diabetes in Pakistan has risen dramatically. There will be 33 million diabetic adults in Pakistan in 2021, a 70% rise from 2019. After China (with 141 million cases) and India (with 102 million), Pakistan presently has the third-highest rate of diabetes prevalence worldwide (74 million). The growth in the prevalence of type 2 diabetes can be attributed to multiple variables, including but not limited to those in the areas of economics, demography, ecology, and heredity. Urbanization, an ageing population, a decline in physical activity, and a rise in overweight and obesity are all contributing factors. In addition to providing useful information for larger-scale diabetes initiatives at the national and provincial levels (and their partners), this study's unique emphasis on the patient's point of view could be seen as groundbreaking (as an illness). The recommended treatment will be interpreted from patient's viewpoint and their respective issues, concerns, challenges and socio-cultural elements at large that may influence or compromise the adherence towards the proposed treatment of diabetes. Therefore, from the patient's vantage point, the proposed treatment's implementation through pilot intervention in chosen health facilities can be understood as an explanatory model of sickness (of/for diabetes). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05865717
Study type Observational
Source Health Services Academy, Islamabad, Pakistan
Contact
Status Completed
Phase
Start date February 15, 2023
Completion date June 21, 2023

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Active, not recruiting NCT04954313 - Baseline Oral Health Study: UnCoVer the Connections to General Health Phase 4
Completed NCT01354925 - Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan Phase 4
Completed NCT01206725 - Exercise Study on Cardiac Function in Patients With Diabetes Mellitus Type 2 and Diastolic Dysfunction N/A
Completed NCT00997282 - A Study of OPC-262 in Patients With Type 2 Diabetes Phase 2/Phase 3
Completed NCT00637546 - Gait and Balance of Diabetes Type 2 Patients Phase 2/Phase 3
Completed NCT00464880 - Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy Phase 1/Phase 2
Withdrawn NCT02057497 - An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms N/A
Active, not recruiting NCT05014204 - Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes N/A
Recruiting NCT03662217 - Personalized Nutrition for Diabetes Type 2 N/A
Completed NCT04276051 - Cryovagotomy Diabetes Trial N/A
Completed NCT02569684 - Effects of Prebiotics on GLP-1 in Type 2 Diabetes N/A
Active, not recruiting NCT01933529 - ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes) Phase 2
Terminated NCT01722474 - Assessment of Three Instruments for the Non-invasive Measurement of Arterial Stiffness. N/A
Completed NCT00977262 - Postprandial Inflammation and Fatty Acids N/A
Completed NCT00518427 - Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine Phase 4
Recruiting NCT05378620 - Project Dulce for Filipino-Americans With Type 2 Diabetes N/A
Recruiting NCT03834207 - A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy N/A
Active, not recruiting NCT05228067 - Enhancing Brain Health by tDCS in Persons With Overweight and Obesity N/A
Active, not recruiting NCT05689684 - Arabinoxylan-oligosaccharides (AXOS) for the Management of Type-2 Diabetes N/A